Blackstone Life Sciences

company

About

Blackstone Life Sciences is a private equity segment of The Blackstone Group.

Details

Operating Status
Active
Investor Type
PE

Blackstone Life Sciences (BXLS) fills a critical void in the industry. While life sciences is seeing unprecedented innovation driven by rapid advancements in science and technology, it often lacks the necessary funding to bring medicines and healthcare technologies to market. We work in partnership with the pharmaceutical, biotechnology and medical technology industries to help meet this need.

Investments

Number of Investments
Number of Lead Investments
2
2
Blackstone Life Sciences has made 2 investments. Their most recent investment was on Mar 15, 2022, when Sanofi raised €300M.
Date Company Name
Round Money Raised Industry Lead Investor
Mar 15, 2022 Sanofi
Post-IPO Equity €300M Health Care Yes
Jun 15, 2020 Medtronic
Post-IPO Equity $337M Biotechnology Yes